US FDA User Fee Staffing: The Objective Capacity Planning Adjuster Often Needs Subjective Review
Executive Summary
The FDA has overruled the results from its own formula intended to match resource levels with workload every time except once.
You may also be interested in...
US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention
Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.
BsUFA III Expands Biosimilar Supplement Review Goals To Speed Approvals
Six supplement categories based on submission content will be created with review goals between three and 10 months.
PDUFA VII Commitment Letter Outlines Real-Time Review Expansion, Hiring Goals
Allergenic extract products, previously excluded, also will become part of the user fee program beginning in FY 2023.